Suchergebnisse - (Person:"Fajgenbaum, David C")

PubPharm (4)

1

Siltuximab administration results in spurious IL-6 elevation in peripheral blood

enthalten in: American journal of hematology | 2024

von Mango, N. | Pierson, S. | Sarmiento Bustamante, M. | +3

2

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2022

von van Rhee, F. | Rosenthal, A. | Kanhai, K. | +4

3

Adrenalitis and anasarca in idiopathic multicentric Castleman's disease

enthalten in: Lancet (London, England) | 2021

von Chen, L. | Skinnider, B. | Wilson, D. | +1

4

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

enthalten in: American journal of hematology | 2020

von Fajgenbaum, D. | Wu, D. | Goodman, A. | +21

1
[1]